Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Lavoie · SciRah

Researcher profile · Semantic Scholar

P. Lavoie

Share profile

P. Lavoie — researcher profile on SciRah

h-index: 17
Works: 66
Citations: 956

Most-cited papers

Comparative Immunochemical Analyses of the Developmental Expression and Distribution of Ameloblastin and Amelogenin in Rat Incisors
A. Nanci, S. Zalzal, P. Lavoie, M. Kunikata +8 more
1998Journal of Histochemistry and Cytochemistry141 citations Open access
Semantic Scholar
Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.
C. Auray-Blais, Michel Boutin, R. Gagnon, Félix O. Dupont +2 more
2012Analytical Chemistry100 citations
Semantic Scholar
Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.
P. Lavoie, Michel Boutin, C. Auray-Blais
2013Analytical Chemistry84 citations
Semantic Scholar
An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.
C. Auray-Blais, P. Lavoie, Hao-Yue Zhang, R. Gagnon +5 more
2012Clinica chimica acta; international journal of clinical chemistry74 citations
Semantic Scholar
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.
C. Auray-Blais, Catherine-Marie Blais, U. Ramaswami, Michel Boutin +10 more
2015Clinica chimica acta; international journal of clinical chemistry70 citations
Semantic Scholar
UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
C. Auray-Blais, P. Lavoie, S. Tomatsu, V. Valayannopoulos +5 more
2016Analytica Chimica Acta64 citations
Semantic Scholar
LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease.
Michel Boutin, R. Gagnon, P. Lavoie, C. Auray-Blais
2012Clinica chimica acta; international journal of clinical chemistry60 citations
Semantic Scholar
Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation.
C. Auray-Blais, P. Lavoie, Michel Boutin, Aimé Ntwari +3 more
2017Clinica chimica acta; international journal of clinical chemistry53 citations
Semantic Scholar
Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders
M. Piraud, Magali Pettazzoni, P. Lavoie, Séverine Ruet +6 more
2018Journal of Inherited Metabolic Disease33 citations
Semantic Scholar
Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.
Mona Abaoui, Michel Boutin, P. Lavoie, C. Auray-Blais
2016Clinica chimica acta; international journal of clinical chemistry32 citations
Semantic Scholar
Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma
S. Ferreira, C. Auray-Blais, Michel Boutin, P. Lavoie +4 more
2015Clinica chimica acta; international journal of clinical chemistry30 citations Open access
Semantic Scholar
Tandem Mass Spectrometry Quantitation of Lyso‐Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients
Michel Boutin, P. Lavoie, Mona Abaoui, C. Auray-Blais
2016Current Protocols in Human Genetics23 citations
Semantic Scholar
Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS/MS.
C. Auray-Blais, P. Lavoie, B. Maranda, Michel Boutin
2016Bioanalysis21 citations
Semantic Scholar
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
G. Effraimidis, U. Feldt-Rasmussen, Å. Rasmussen, P. Lavoie +3 more
2020Journal of Medical Genetics18 citations
Semantic Scholar
High-Risk Screening for Fabry Disease in a Canadian Cohort of Chronic Kidney Disease Patients.
C. Auray-Blais, P. Lavoie, Mona Abaoui, A. Côté +5 more
2019Clinica chimica acta; international journal of clinical chemistry18 citations
Semantic Scholar
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.
R. Limgala, Tabitha Jennelle, Matthew Plassmeyer, Michel Boutin +6 more
2019American journal of translational research17 citations
Semantic Scholar
High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.
C. Auray-Blais, B. Maranda, P. Lavoie
2014Clinica chimica acta; international journal of clinical chemistry17 citations
Semantic Scholar
Fabry Disease Biomarkers: Analysis of Urinary Lyso‐Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry
P. Lavoie, Michel Boutin, Mona Abaoui, C. Auray-Blais
2016Current Protocols in Human Genetics12 citations
Semantic Scholar
Neonatal Urine Screening Program in the Province of Quebec: Technological Upgrade from Thin Layer Chromatography to Tandem Mass Spectrometry
C. Auray-Blais, Michel Boutin, P. Lavoie, B. Maranda
2021International Journal of Neonatal Screening11 citations Open access
Semantic Scholar
High‐Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb3) in Urine Collected on Filter Paper
C. Auray-Blais, P. Lavoie, Michel Boutin, Mona Abaoui
2017Current Protocols in Human Genetics11 citations
Semantic Scholar
Mass Spectrometry Analysis of Globotriaosylsphingosine and Its Analogues in Dried Blood Spots
Michel Boutin, P. Lavoie, Margot Beaudon, Georges Kabala Ntumba +3 more
2023International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Successful reversal of transgene silencing in Chlamydomonas reinhardtii
Rémy Beauchemin, Natacha Mérindol, E. Fantino, P. Lavoie +3 more
2023Biotechnology Journal9 citations Open access
Semantic Scholar
Analysis of globotriaosylceramide (Gb3) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometry.
Amanda Toupin, P. Lavoie, M. Arthus, Mona Abaoui +5 more
2018Analytica Chimica Acta9 citations
Semantic Scholar
Distribution of heparan sulfate and dermatan sulfate in mucopolysaccharidosis type II mouse tissues pre- and post-enzyme-replacement therapy determined by UPLC-MS/MS.
Iskren Menkovic, P. Lavoie, Michel Boutin, C. Auray-Blais
2019Bioanalysis8 citations
Semantic Scholar
UPLC–MS/MS analysis of keratan sulfate from urine samples collected on filter paper for monitoring & follow-up of Morquio A patients
C. Auray-Blais, Jasmin Collerette-Tremblay, P. Lavoie
2018Bioanalysis7 citations
Semantic Scholar
Protein Synthesis by Ameloblasts and Selective Accumulation of Some Nonamelogenins at Enamel Growth Sites
A. Nanci, S. Zalzal, J. Hashimoto, P. Lavoie +7 more
19986 citations
Semantic Scholar
Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy
C. Auray-Blais, P. Lavoie, Tristan Martineau, C. A. Rupar +6 more
2024Rare Disease and Orphan Drugs Journal5 citations Open access
Semantic Scholar
Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles
Michel Boutin, P. Lavoie, Iskren Menkovic, Amanda Toupin +8 more
2020International Journal of Molecular Sciences5 citations Open access
Semantic Scholar
High‐Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non‐Methylated Gb3 Isoforms Using Tandem Mass Spectrometry
Mona Abaoui, Michel Boutin, P. Lavoie, C. Auray-Blais
2016Current Protocols in Human Genetics3 citations
Semantic Scholar
Fabry disease biomarkers in patients switched from enzyme replacement therapy to migalastat oral chaperone therapy.
C. Auray-Blais, P. Lavoie, Tristan Martineau, Georges Kabala Ntumba +8 more
2023Bioanalysis2 citations
Semantic Scholar
Multiplex Quantification of Plasma Biomarkers for Patients with Gaucher Disease Type 1
Iskren Menkovic, Michel Boutin, P. Lavoie, C. Auray-Blais
2023Current Protocols2 citations Open access
Semantic Scholar
Urine keratan sulfate (uKS) elevation in lysosomal disorders (LSD): Comparison of uKS levels in Morquio/MPS IV versus non-Morquio LSD
C. Auray-Blais, D. Millington, F. Wijburg, T. Wood +7 more
20151 citations
Semantic Scholar
Gene therapy for Fabry disease patients: The importance of efficient biomarker monitoring
C. Auray-Blais, Michel Boutin, P. Lavoie, R. Casey +6 more
20131 citations
Semantic Scholar
What about newborn urine screening possibilities using samples collected on filter paper by parents?
C. Auray-Blais, P. Lavoie, Bruno Maranda
2026Molecular Genetics and Metabolism0 citations
Semantic Scholar
Feasibility of newborn screening of triple H syndrome using dried urine spots analyzed by flow-injection mass spectrometry
C. Auray-Blais, P. Lavoie, Bruno Maranda
2025Molecular Genetics and Metabolism0 citations
Semantic Scholar
Fabry disease biomarker evaluation during a five-year gene therapy clinical trial
C. Auray-Blais, P. Lavoie, Tristan Martineau, Tony Rupar +6 more
2025Molecular Genetics and Metabolism0 citations
Semantic Scholar
Analysis by tandem mass spectrometry of lyso-Gb and related analogues in dried blood spots: A convenient way to monitor patients affected with Fabry disease
C. Auray-Blais, P. Lavoie, Georges Kabala Ntumba, Daniel G. Bichet +1 more
2024Molecular Genetics and Metabolism0 citations
Semantic Scholar
The investigation of the profiles of Lyso-Gb3 and related analogues in children with Fabry disease using tandem mass spectrometry
Grigorios Effraimidis, C. Auray-Blais, P. Lavoie, Allan Lund +1 more
2024Molecular Genetics and Metabolism0 citations
Semantic Scholar
Technological update of the Provincial Neonatal Urine Screening Program in Quebec
C. Auray-Blais, P. Lavoie, Bruno Maranda
2024Molecular Genetics and Metabolism0 citations
Semantic Scholar
Discovery of novel MPS II neuronopathic biomarkers using untargeted metabolomic approaches
A. Farjallah, P. Lavoie, Bruno Maranda, Roberto Giugliani +1 more
2024Molecular Genetics and Metabolism0 citations
Semantic Scholar
Glycosphingolipid evaluation for Fabry disease patients receiving migalastat after switching from enzyme replacement therapy
C. Auray-Blais, P. Lavoie, Tristan Martineau, Georges Kabala Ntumba +8 more
2024Molecular Genetics and Metabolism0 citations
Semantic Scholar
Tandem mass spectrometry analysis of dried urine spots for newborn screening of mucopolysaccharidoses
C. Auray-Blais, Iskren Menkovic, Michel Boutin, P. Lavoie
2023Molecular Genetics and Metabolism0 citations
Semantic Scholar
Can the use of urinary and plasma globotriaosylsphingosine and their analogues as diagnostic biomarkers be confirmed in male patients with Fabry disease?
G. Effraimidis, C. Auray-Blais, P. Lavoie, Å. Rasmussen +1 more
2023Molecular Genetics and Metabolism0 citations
Semantic Scholar
X chromosome inactivation, ⍺-galactosidase A activity and lyso-Gb in Danish heterozygous females with Fabry disease
G. Effraimidis, M. Duno, Å. Rasmussen, C. Kistorp +3 more
2022Molecular Genetics and Metabolism0 citations Open access
Semantic Scholar
BIOINFORMATICS PROFILING OF SALIVARY AMELOBLASTIN
H. S. Mohideen, Sherlin Hj, P. Krebsbach, S. Lee +49 more
2021International Journal of Biology Pharmacy and Allied Sciences0 citations Open access
Semantic Scholar
The importance of mass spectrometry-based untargeted metabolomic approaches for biomarker discovery in lysosomal diseases
C. Auray-Blais, Michel Boutin, Marcel A Kelkel, Iskren Menkovic +2 more
20210 citations
Semantic Scholar
Globotriaosylsphingosine (Lyso-Gb) and analogues in plasma and urine of Fabry disease patients and relation to long-term treatment in a nationwide female Danish cohort: A retrospective study of a prospective cohort
Grigorios Effraimidis, U. Feldt-Rasmussen, Å. Rasmussen, P. Lavoie +1 more
20200 citations
Semantic Scholar
High-risk screening for Fabry disease in chronic kidney disease patients
P. Lavoie, Michel Boutin, Mona Abaoui, A. Côté +4 more
2019Molecular Genetics and Metabolism0 citations
Semantic Scholar
Newborn mass urine screening for Morquio syndrome type A patients using an innovative UPLC-MS/MS approach
C. Auray-Blais, B. Maranda, P. Lavoie
2019Molecular Genetics and Metabolism0 citations
Semantic Scholar
Mass or high-risk screening of mucopolysaccharidoses using urine samples collected on filter paper
C. Auray-Blais, P. Lavoie
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Auray-Blais×45
Invite
C. Auray-Blais — researcher profile on SciRah
Michel Boutin×25
Invite
Michel Boutin — researcher profile on SciRah
Mona Abaoui×11
Invite
Mona Abaoui — researcher profile on SciRah
B. Maranda×8
Invite
B. Maranda — researcher profile on SciRah

×5

Invite

J. Clarke — researcher profile on SciRah

Iskren Menkovic×5

Invite

Iskren Menkovic — researcher profile on SciRah

Tristan Martineau×5

Invite

Tristan Martineau — researcher profile on SciRah

Bruno Maranda×5

Invite

Bruno Maranda — researcher profile on SciRah

Invite

D. Bichet — researcher profile on SciRah

Invite

Aneal Khan — researcher profile on SciRah

Invite

A. Nanci — researcher profile on SciRah

Invite

S. Zalzal — researcher profile on SciRah